Androgen up-regulated VEGF in CWR22 human prostate cancer model

被引：0
|
作者：
Zhang, S [1 ]
Dominguez, J [1 ]
Eble, JN [1 ]
Cheng, L [1 ]
机构：
[1] Indiana Univ, Sch Med, Indianapolis, IN USA
来源：
LABORATORY INVESTIGATION | 2002年 / 82卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
788
引用
收藏
页码：188A / 189A
页数：2
相关论文
共 50 条
  • [31] Androgen receptor is up-regulated by a BLT2-linked pathway to contribute to prostate cancer progression
    Lee, Jin-Wook
    Kim, Geun-Young
    Kim, Jae-Hong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 420 (02) : 428 - 433
  • [32] Androgen suppresses PML protein expression in prostate cancer CWR22R cells
    Yang, L
    Yeh, SD
    Xie, SZ
    Altuwaijri, S
    Ni, J
    Hu, YC
    Chen, YT
    Bao, BY
    Su, CH
    Chang, CS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 314 (01) : 69 - 75
  • [33] The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancer
    Comuzzi, B
    Nemes, C
    Schmidt, S
    Jasarevic, Z
    Lodde, M
    Pycha, A
    Bartsch, G
    Offner, F
    Culig, Z
    Hobisch, A
    JOURNAL OF PATHOLOGY, 2004, 204 (02): : 159 - 166
  • [34] Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model, CWR22-R
    Lukas Amler
    David Agus
    Carrie LeDuc
    Lisa Sapinoso
    William Fox
    Suzanne Kern
    Dori Lee
    Vivian Wang
    Mauri Leysens
    Brian Higgins
    Jason Martin
    William Herald
    Nicholas Dracopoli
    Carlos Cordon-Cardo
    Howard Scher
    Garret Hampton
    Nature Genetics, 2001, 27 (Suppl 4) : 39 - 39
  • [35] Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R
    Amler, LC
    Agus, DB
    LeDuc, C
    Sapinoso, ML
    Fox, WD
    Kern, S
    Lee, D
    Wang, V
    Leysens, M
    Higgins, B
    Martin, J
    Gerald, M
    Dracopoli, N
    Cordon-Cardo, C
    Scher, HI
    Hampton, GM
    CANCER RESEARCH, 2000, 60 (21) : 6134 - 6141
  • [36] Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORF
    Liu, Guozheng
    Dou, Shuping
    Pretorius, P. Hendrik
    Liu, Xinrong
    Rusckowski, Mary
    Hnatowich, Donald J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (02) : 272 - 280
  • [37] Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells
    Yamasaki, Mutsushi
    Nomura, Takeo
    Sato, Fuminori
    Mimata, Hiromitsu
    ONCOLOGY REPORTS, 2007, 18 (05) : 1145 - 1153
  • [38] Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells
    Yamasaki, Mutsushi
    Nomura, Takeo
    Matsubara, Takanori
    Hirai, Kenichi
    Sato, Fuminori
    Mimata, Hiromitsu
    CANCER RESEARCH, 2009, 69
  • [39] Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORF
    Guozheng Liu
    Shuping Dou
    P. Hendrik Pretorius
    Xinrong Liu
    Mary Rusckowski
    Donald J. Hnatowich
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 272 - 280
  • [40] A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
    Guo, Zhiyong
    Yang, Xi
    Sun, Feng
    Jiang, Richeng
    Linn, Douglas E.
    Chen, Hege
    Chen, Hegang
    Kong, Xiangtian
    Melamed, Jonathan
    Tepper, Clifford G.
    Kung, Hsing-Jien
    Brodie, Angela M. H.
    Edwards, Joanne
    Qiu, Yun
    CANCER RESEARCH, 2009, 69 (06) : 2305 - 2313
12345